Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Aims Frequent glucose testing is required for optimal management of type 1 diabetes (T1D). Limited data are available regarding real-world experience of the novel technology for monitoring by continuous interstitial fluid glucose (IFG), using flash glucose-sensing technology (FSL-CGM). We aimed to assess the effect of FSL-CGM in a real-life clinical setting on glycemic control parameters, compliance, and adverse events among pediatric and young adult T1D patients. Methods This observational multi-center study assessed FSL-CGM use (6-12 months) in T1D patients (mean ± SD age 13.4 ± 4.9 years) who purchased the device out-of-pocket. Outcome measures included HbA1c, mean IFG levels, CGM metrics [time in hypoglycemia ( 240 mg/dL; > 13.3 mmol/L)], frequency of self-monitoring of blood glucose, acute complications, skin reactions, and reasons for initiation/discontinuation. Results Among patients with regular use of the FSL-CGM (n = 59), mean HbA1c decreased from 8.86 ± 0.23 to 8.05 ± 0.2% (73.3-64.5 mmol/mol) in 3 months (p = 0.0001) and plateaued thereafter. A clinically significant reduction in HbA1c (defined as a decrease of ≥ 0.5%) was associated with shorter diabetes duration. Of 71 patients who initiated use of the FSL-CGM, 12 (16.9%) discontinued during the study period. No statistically significant changes were found after FSL-CGM use, in mean and standard deviation IFG levels, and in time of glucose levels in target, hypoglycemia, and hyperglycemia ranges. One patient wit…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505 · cited 5×
“Self-monitoring of blood glucose (SMBG) by finger prick tests has been the standard of care for diabetes for the last few decades [1]; its value for better glycemic control has been clearly demonstrated among all insulintreated patients whether treated by multiple daily insulin injections or by continuous subcutaneous…”
BackgroundInfluentialZiegler, R., Heidtmann, B., Hilgard, D., Hofer, S., Rosenbauer, J., Holl, R., & DPV-Wiss-Initiative, F. T. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00650.x · Cited by 334
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245
Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.015 · Cited by 239
Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control
Duca, L. M., Wang, B., Rewers, M., & Rewers, A. (2017) · Diabetes Care · doi:10.2337/dc17-0558 · Cited by 236
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 250
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020) · Diabetes Care · doi:10.2337/dc19-1610 · Cited by 261
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Evans, M., Welsh, Z., Ells, S., & Seibold, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00720-0 · Cited by 185
“…4 4 Weiss 2018 [32] Unknown Adults Mix* 22 8.70 - 1.00 0.262 Löndahl 2017 [33] 3 Adults 1 226 8.72 - 0.65 0.050 4 4 12 Adults 1 226 8.72 - 0.74 0.063 4 Landau 2018 [34] 3 Children 1 59 8.86 - 0.81 0.031 4 Ish-Shalom 2016 [35] 1 Adults 1 and 2 6 and 25 8.90 - 0.80 0.178 4 2 Adults 1 and 2 6 and…”
InfluentialRoussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Tauschmann, M., Forlenza, G., Hood, K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13451 · Cited by 100
“80,81,85,87,88 These studies were all performed using first-generation systems without alarms for impending hypo-and hyperglycemia.”
Asarani, N. A. M., Reynolds, A. N., Boucher, S. E., de Bock, M., & Wheeler, B. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 81
Castellana, M., Parisi, C., Di Molfetta, S., Di Gioia, L., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001092 · Cited by 84
Tauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
Al Hayek, A. A., & Al Dawish, M. A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0616-4 · Cited by 66
Brener, A., Mazor‐Aronovitch, K., Rachmiel, M., Levek, N., Barash, G., Pinhas‐Hamiel, O., Lebenthal, Y., & Landau, Z. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01596-4 · Cited by 67
“* Avivit Brener Avivit.brener@gmail.com; avivitb@tlvmc.gov.il 1 Pediatric Endocrinology and Diabetes Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 6423906 Tel Aviv, Israel 2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3 Pediatric Endocrine and Diabetes…”
MethodSelf-citationBoucher, S. E., Gray, A. R., Wiltshire, E. J., de Bock, M. I., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., Chan, H., Rose, S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0613 · Cited by 51
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
Al Hayek, A. A., Robert, A. A., & Al Dawish, M. A. (2019) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.1177/1179551419861102 · Cited by 44
Gordon, I., Rutherford, C., Makarounas‐Kirchmann, K., & Kirchmann, M. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108158 · Cited by 40
A porous microneedle electrochemical glucose sensor fabricated on a scaffold of a polymer monolith
Kai, H., & Kumatani, A. (2021) · Journal of Physics Energy · doi:10.1088/2515-7655/abe4a1 · Cited by 35
“The measurement range covers a part of the concentration range of glucose in skin interstitial fluid of a human body (up to ∼20 mM) [24].”
BackgroundRachmiel, M., Lebenthal, Y., Mazor‐Aronovitch, K., Brener, A., Levek, N., Levran, N., Chorna, E., Dekel, M., Barash, G., Landau, Z., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01673-2 · Cited by 29
Self-citationStyles, S. E., Aum, S., Crocket, H. R., Wiltshire, E. J., Tomlinson, P. A., de Bock, M. I., & Wheeler, B. J. (2019) · Diabetic Medicine · doi:10.1111/dme.14188 · Cited by 24
Styles, S. E., Gray, A. R., de Bock, M. I., Wiltshire, E. J., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., & Wheeler, B. J. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0378-z · Cited by 25
“5% in HbA1c) among T1D patients aged 1–25 years being sustained at 12 months [32] in a real-world setting.”
BackgroundBahillo-Curieses, P., Díaz-Soto, G., Martínez, A. M. V., Ballester, I. T., Hoyos, E. G., & Román, D. A. D. L. (2021) · Endocrine · doi:10.1007/s12020-021-02691-4 · Cited by 21
Hayek, A. A., Robert, A. A., & Dawish, M. A. A. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420910122 · Cited by 21
Romero‐Castillo, R., Pabón‐Carrasco, M., Picón, N. J., & Ponce‐Blandón, J. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095079 · Cited by 17
“They can meet target glucose levels and average periods of hypoglycemia and hyperglycemia, as well as set alarms to notify them of high or low blood glucose levels [15,16].”
Backgroundvon Kobyletzki, L. B., Ulriksdotter, J., Sukakul, T., Aerts, O., Agner, T., Buhl, T., Bruze, M., Foti, C., Giménez‐Arnau, A. M., Gonçalo, M., et al. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19908 · Cited by 17
Charleer, S., Gillard, P., Vandoorne, E., Cammaerts, K., Mathieu, C., & Casteels, K. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13128 · Cited by 14
“Seventeen percent reported the development of skin reactions and is in line with other reported incidences in children.(16,21) To the best of our knowledge, this is the first long-term study assessing changes in school and work absence after initiation of CGM”
BackgroundResultGlennie, J. L., Berard, L., & Levrat‐Guillen, F. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s346736 · Cited by 34
Dead in bed – A systematic review of overnight deaths in type 1 diabetes
Jones, J., James, S., Brown, F., O'Neal, D. N., & Ekinci, E. I. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110042 · Cited by 12
Biester, T., Grimsmann, J. M., Heidtmann, B., Rami-Merhar, B. M., Ermer, U., Wolf, J., Freff, M., Karges, B., Agena, D., Bramlage, P., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0373 · Cited by 13
“32 Furthermore, with a median HbA1c of 6.8%, this group with HbA1c 7.5% also meets the current ISPAD guidelines ( 7.0%).”
InfluentialZhang, L., Xu, Y., Jiang, X., Wu, J., Liu, F., Fan, L., Li, X., Yin, G., & Yang, L. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13693 · Cited by 8
Du, M., Yi, S., Wei, Y., Jiang, Y., Bao, S., Lu, J., & Chen, D. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01749-0 · Cited by 6
de Portu, S., Vorrink, L., Ré, R., Shin, J., Castañeda, J., Habteab, A., & Cohen, O. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050635 · Cited by 7
Marsters, B. L., Styles, S. E., Galland, B. C., Wiltshire, E. J., de Bock, M. I., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., Chan, H., & Wheeler, B. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13121 · Cited by 6
Gea, I. L., Lirio, M. F. M., Gómez‐Perea, A., Jiménez, A. B. A., Ceballos, L. T., Hinojosa, J. M. J., & López‐Siguero, J. P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020286 · Cited by 5
“These data had already been published with the number of capillary glycemic controls per day, where it was seen that a greater number of capillary glucose controls were related to better control measures of hemoglobin [12]; however, from a certain number, this was related to caregiver anxiety, and/or the patient, with…”
BackgroundMethodMedina, A. M. G., Yepes, C. A., Duarte-Osorio, A., Henao, D. C., Jaramillo-Parra, P., Stephens-Leal, I., García-Morales, O. M. P., Rubio, C., Salej-Durán, V., Monroy, G., et al. (2022) · Acta Médica Colombiana · doi:10.36104/amc.2022.2239 · Cited by 5
Gürkan, K. P., Ayar, D., Karadağ, G., Böber, E., & Demir, K. (2022) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2022.01.020 · Cited by 4
Abulqasim, J., Alotaibi, F., & Khalifah, R. A. A. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0452 · Cited by 3
Monitoreo Continuo de Glucosa. ¿Qué evidencia tenemos en pediatría?
Ayala, D. V. S., Forero, C., Mauricio Coll, B., Durán, P. A., & Céspedes, C. (2021) · Andes pediatrica · doi:10.32641/andespediatr.v92i4.2973 · Cited by 5
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Addala, A., & Shalitin, S. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.2507 · Cited by 2
“Also data from real-world experience showed that the use of isCGM was associated with a significant improved glycemic control (18,19) and improved hypoglycemia awareness and a reduction in hospital admissions (19).”
Riveline, J., Guerci, B., Wojtusciszyn, A., & Dunn, T. C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.08.001 · Cited by 5
Baker, R. K., Filipp, S. L., & Jacobsen, L. M. (2023) · Diabetes Spectrum · doi:10.2337/ds22-0061 · Cited by 1
González‐Pacheco, H., Rivero‐Santana, A., Ramallo‐Fariña, Y., Valcárcel‐Nazco, C., Álvarez‐Pérez, Y., García‐Pérez, L., Bello, M. Á. G., Perestelo‐Pérez, L., & Serrano‐Aguilar, P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071334 · Cited by 2
The Application of Digital Health in Diabetes Management
Ye, J. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v66i.11711 · Cited by 1
Kandiyali, R., & Taylor, H. (2022) · medRxiv · doi:10.1101/2022.11.22.22281186 · Cited by 1
“A multi-centre observational study in Israel, [14] found that self-funded regular (nondiscontinuing n=59/71) users (children and young people aged 4-23 years) of Libre experienced significant reductions in HbA1c 8.”
BackgroundInfluentialAktuelle Therapien und Technologien in der Kinderdiabetologie
Bartelt, H., Klamt, S., Thiele, A. G., Sergeyev, E., Kieß, W., & Kapellen, T. M. (2020) · Kinder- und Jugendmedizin · doi:10.1055/a-1065-7281
Introduction on Use of Technology in Pediatric Type 1 Diabetes
Zucchini, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-42806-8_1
Glucose flash monitoring systems: sources of funding, procurement and delivering to patients
Федоров, А. А., Сергеевна, П. О., & Ratushnyak, S. S. (2021) · Medical Technologies Assessment and Choice · doi:10.17116/medtech20214304144
Comité de Innovación. Uso de los sistemas de infusión continua de insulina en personas con DM1
Carnero, R., Saleme, A., Lequi, L., Daín, A., Campos, F. S., Sosa, L., Flores, A., & Kabakian, L. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.763 · Cited by 1
Lirio, M. F. M. (2025) · Repositorio Institucional de la Universidad de Málaga (University of Málaga)
Jarl, S. M. (2021) · Duo Research Archive (University of Oslo)
Duran, P. A. A., Suárez, M. B., Matallana, A. M., Céspedes, C., Llano, J. P., & Pinzón-Serrano, E. (2026) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.13.2.954
Diabetes Technology in Children
Zhou, Y., & Wheeler, B. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-24854-1_14
Metadata
- Authors
- Landau, Z., Abiri, S., Gruber, N., Levy-Shraga, Y., Brener, A., Lebenthal, Y., Barash, G., Pinhas-Hamiel, O., & Rachmiel, M.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Landau, Zohar
- Venue
- Acta Diabetologica
- Published
- 2018-08-31
- Volume
- 55
- Issue
- 12
- Pages
- 1303-1310
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2888917246
- Semantic Scholar
- 87b5a4b5b7c346573ab04706ce8ad43f5bdfc719
- Cited by
- 48
- References
- 27
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 12 · 2019: 9
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-09-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, flash glucose monitoring, FreeStyle Libre, continuous glucose monitoring, glycemic control, HbA1c, hypoglycemia, hyperglycemia, self-monitoring of blood glucose, hypoglycemia unawareness, device discontinuation, pediatric and young adult patients, diabetes duration, skin reactions, acute complications, real-world applications
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Humans, Hyperglycemia, Hypoglycemia, Male, Patient Compliance, Blood Glucose Self-Monitoring, Biosensing Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.